Indeed, high expression of NKG2A on NK cells and cytotoxic CD8 T cells happens in the tumor microenvironment as a result of PD-1 blockade therapy as well as after immune activation by cancer vaccines (7). This evidence concerns the gene KLRC1 and neoplasm.